Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

Evan A. Stein, Robert P. Giugliano, Michael J. Koren, +12

European Heart Journal

Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis

Balázs Gasz, Bóglárka Rácz, E. Rőth, +9

Peptides

InflammationCardiac MuscleCardiomyopathyHeart FailurePituitary Gland +13

Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis

Bóglárka Rácz, Balázs Gasz, Balázs Borsiczky, +12

General and Comparative Endocrinology

InflammationPituitary GlandEndothelial CellsMedicineLipid Peroxidation +11

PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis

Bóglárka Rácz, Balázs Gasz, Ferenc Gallyas, +9

Regulatory Peptides

InflammationCardiomyopathyHeart FailureMolecular PhysiologySignal Transduction +12

Perioperative TNF alpha and IL-6 concentrations correlate with septic state, organ function, and APACHE II scores in intra-abdominal infection.

R. Függer, E Zadrobilek, P. Götzinger, +7

PubMed

Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium

M T Jaberansari, Gary F. Baxter, C. A. Muller, +4

Journal of the American College of Cardiology

Cardiac MuscleMolecular PhysiologyMedicinePhysiologyCardiovascular Pharmacology +8

Pathology and diagnostic options of lower limb compartment syndrome

Endre Arató, M. Kürthy, L. Sínay, +7

Clinical Hemorheology and Microcirculation

Effects of PACAP and Preconditioning against Ischemia/Reperfusion‐induced Cardiomyocyte Apoptosis<i>In Vitro</i>

E. Rőth, G. Wéber, P. Kiss, +7

Annals of the New York Academy of Sciences

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial

Eliot A. Brinton, Uma Kher, Sukrut Shah, +151

Journal of clinical lipidology

Specific Patient SubgroupsPharmacologyCetp InhibitionHyperlipidemiaPharmacotherapy +4

Spatial recording of disappearance constants of xenon-133 washout from the lung.

MacIntyre Wj, Inkley, E. Rőth, +2

PubMed

Lung DepositionHealth SciencesMedical ImagingPulmonary CirculationPhysiology +9